Rat Corpus Cavernosum Smooth Muscle Cells

Primary rat corpus cavernosum smooth muscle cells (CCSMCs), isolated by enzymatic dispersion from rat penile crura, constitute the principal cellular regulator of penile hemodynamics, governing both erection and detumescence. In culture, they faithfully retain their native phenotype, providing a powerful and physiologically authentic in vitro system for erectile biology research.

A principal advantage of rat CCSMCs is their robust preservation of a differentiated, contractile phenotype. The cells exhibit the classic spindle-shaped morphology and strongly express a full panel of smooth muscle markers, including α-smooth muscle actin, calponin, smooth muscle myosin heavy chain, and desmin. Functionally, they mount potent, dose-dependent contractions to α1-adrenergic agonists (e.g., phenylephrine) and endothelin-1, and relax in response to nitric oxide donors, natriuretic peptides, or direct activators of soluble guanylyl cyclase, enabling direct mechanistic dissection of the NO-cGMP and RhoA/ROCK signaling pathways central to penile erection. Critically, rat CCSMCs maintain high endogenous expression of phosphodiesterase type 5 (PDE5), the molecular target of sildenafil, making them an ideal platform for evaluating PDE5 inhibitors and novel relaxant agents.

The rat origin confers high availability, low cost, and seamless integration with established rodent models of erectile dysfunction—including diabetes, cavernous nerve injury, castration, and hypertension. This allows precise in vitro–in vivo correlation of molecular alterations such as phenotypic switching to a synthetic or fibrotic state, apoptosis, and oxidative stress. Collectively, primary rat CCSMCs offer an indispensable, translationally relevant platform for dissecting erectile physiology, elucidating the pathogenesis of erectile dysfunction, and screening candidate therapeutics.